AveXis
Biotech company is focused on developing gene therapy for patients with rare and life-threatening neurological genetic diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
$260—390m (Dealroom.co estimates Sep 2015.)
Dallas Texas (HQ)
Authorizing premium user...